Infection and Immunity, March 2000, p. 1243-1251, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Division of Rheumatology, Toronto Western Hospital,1 and Departments of Medicine,2 Immunology,3 and Laboratory Medicine and Pathobiology,4 University of Toronto, Toronto, Canada
Received 2 August 1999/Returned for modification 30 September 1999/Accepted 12 November 1999
| |
ABSTRACT |
|---|
|
|
|---|
Tumor necrosis factor (TNF) has generally been regarded as a
protective cytokine in host defense against bacterial infections. In
the present study, we evaluated the role of TNF in the acute phase of
infection by Yersinia enterocolitica by using mice rendered genetically deficient in TNF receptor p55 (TNFRp55
/
).
Unexpectedly, TNFRp55
/
mice showed more effective
resistance to the bacteria, reflected in enhanced bacterial clearance
and less tissue damage, than did control C57BL/6 mice. C57BL/6 mice
showed evidence of extensive apoptosis in the spleen accompanied by a
selective decrease in the CD4+-T-cell population of
splenocytes, whereas TNFRp55
/
mice were spared these
changes. The splenocytes from TNFRp55
/
mice also
maintained a robust gamma interferon IFN-
response to mitogenic
stimulation, while the comparable response in C57BL/6 mice was
impaired. In addition, splenocytes harvested from infected mice
demonstrated lower production of interleukin-10 IL-10 in TNFRp55
/
mice than in C57BL/6 mice. These findings
suggest that Yersinia can induce TNFRp55-mediated apoptosis
of splenocytes in the acute phase of the infection and that
alteration of T-cell-generated cytokines can dramatically alter
the early events in host defense against this pathogen.
| |
INTRODUCTION |
|---|
|
|
|---|
Yersinia enterocolitica
is a gram-negative pathogen that causes enteritis and enterocolitis in
humans and rodents (17). Systemic infections can cause
abscesses and granulomatous lesions in the spleen and liver
(12). Furthermore, immunopathological sequelae of
Yersinia infection such as reactive arthritis are well
recognized (17). An effective cell-mediated immune response required to overcome infection with Yersinia is controlled
by different cell types and their respective cytokines (1, 5, 8,
9, 11). It has been demonstrated that in the first 3 days after
Y. enterocolitica infection, innate host defense mechanisms,
particularly involving Mac-1+ phagocytes and NK cells, play
a role in controlling the growth of this pathogen in host tissues
(2, 4). Thereafter, a specific T-cell response accounts for
resolution of the interaction (2, 4), with CD4+
Th1 cells playing a critical protective role (5). A balance between Th1 and Th2 cytokines has been proposed to influence the outcome of Yersinia infection (8), especially in
the early stages of host defense. Gamma interferon (IFN-
), produced
by NK cells and CD4+ T cells, is associated with resistance
of mice to Yersinia (3), and interleukin-12
(IL-12) is essential in enhancing IFN-
production (8). In
contrast, anti-IL-4 antibodies render BALB/c mice resistant to
Yersinia (8). IL-10 acts antagonistically to
IL-12 during yersinosis in BALB/c mice (11).
Tumor necrosis factor (TNF), produced primarily by monocytes and T
cells, has also been considered a critical cytokine in activating
macrophages in the protective host response to Yersinia. Increased TNF levels are associated with host resistance to
Yersinia (13). However, TNF is a pleiotropic
cytokine that can exert both beneficial and detrimental effects in
bacterial infections (6), and the precise biologic
mechanisms underlying the action of TNF in Yersinia
infection have not yet been defined. TNF exerts its biologic activity
via two receptors, TNFRp55 and TNFRp75. TNFRp55 is known to mediate
most of the effects of TNF, including cytotoxicity mediated by necrosis
and apoptosis, activation of macrophages, and up-regulation of adhesion
molecules (6). Studies of TNFRp55 gene-targeted mice have
revealed that in the absence of TNFRp55, the mice are highly
susceptible to infection with Listeria monocytogenes,
Mycobacterium tuberculosis, and Salmonella enterica serovar Typhimurium (18, 20, 23). A recent
study by Bohn et al. demonstrated that TNFRp55-mediated mechanisms are essential for clearance of infection with Y. enterocolitica
WA-314, a less virulent strain of serotype O:8 (10).
However, mice lacking TNFRp55 are able to eliminate Leishmania
major at the site of infection, although they do not heal their
lesion (37, 48). A recent study also showed that TNF
receptor signaling is not required for early control of
Toxoplasma gondii but is critical for the prevention of
toxoplasmic encephalitis later in infection (51). These
studies demonstrated that macrophage activation appears to be largely
unimpaired in the early phase of the infections in
TNFRp55
/
mice, suggesting that cells other than
macrophages are the primary effector of TNF receptor-dependent
resistance during a certain stages of microbial infections.
Using a murine model of hematogenous Y. enterocolitica
infection, we have recently demonstrated that TNFRp55 plays a critical role in host resistance to chronic infection with Y. enterocolitica strain 8081 (54).
TNFRp55
/
mice succumbed to infection with Y. enterocolitica after 2 weeks, with a higher mortality rate than
C57BL/6 mice. Increased bacterial growth in the liver, spleen, and
lungs was observed in TNFRp55
/
mice compared with
control mice on day 14 after infection. This was associated with
impaired macrophage bactericidal activity including nitric oxide
production and oxidative burst activity. Of interest, we observed that
TNFRp55
/
mice appeared capable of limiting acute
infection with different numbers of Y. enterocolitica
bacteria (54) and that all the mice survived the acute
infection. To explore the mechanisms whereby TNFRp55
/
mice respond in the acute phase of infection with Y. enterocolitica, we have investigated the cellular responses to
Yersinia at the early stage in TNFRp55
/
and
C57BL/6 mice. In the present study, we observed more efficient bacterial clearance and reduced tissue damage at the early stage of the
infection in TNFRp55
/
mice. The early defense against
Y. enterocolitica in TNFRp55
/
mice is
associated with less apoptosis in splenocytes and the presence of
increased total numbers of CD4+ T cells compared with those
in control C57BL/6 mice.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Mice.
Breeding pairs of homozygous TNFRp55
/
mice on a C57BL/6 background (38) were kindly provided by T. Mak (Amgen Institute and the University of Toronto, Toronto, Canada)
and bred under specific-pathogen-free conditions. Control C57BL/6 mice
were purchased from Charles River (Montreal, Canada). All mice were
maintained at the animal facility in the Toronto Hospital, Western
Division. For infections we used 6- to 10-week-old mice of both sexes
that were housed in microisolators.
Infection of animals.
Y. enterocolitica strain 8081, a
virulent serotype O:8 strain harboring the pYV plasmid, was used in the
experiments (26). The presence of the virulence plasmid was
confirmed by immunofluorescence staining using plasmid-encoded
fibrillar outer membrane protein Yad A-specific monoclonal antibody 8D1
(kindly provided by Dr. J. Heesemann, Max von Pettenkofer
Institute, Munich, Germany) (41). The bacteria were
cultivated at 24°C in Luria broth (LB) (Difco, Detroit, Mich.),
harvested during the log phase, and frozen at
80°C in LB containing
25% glycerol. Freshly thawed bacteria were prepared in
phosphate-buffered saline (PBS), and mice were inoculated intravenously
in a tail vein with 0.2 ml of the bacterial solution. The number of
bacteria administered was determined by plating serial dilutions of the
inoculum on Yersinia selective agar (Difco) and Luria broth
agar (Difco), and the CFU were counted after an incubation period of
40 h at 24°C. TNFRp55
/
and C57BL/6 mice were
inoculated with 350 CFU of the bacteria and were sacrificed on day 5 after infection. Blood samples were obtained before death. The organs
including spleen, liver, lungs, and kidneys were collected for analysis.
Histologic examination and apoptosis detection. Histopathologic examination of the liver and spleen was performed after routine fixation, decalcification, and paraffin embedding. Tissue sections were stained with hematoxylin-eosin, and the results were evaluated by two observers, each of whom read the slides blindly. The specimens were evaluated with regard to abscesses, necrotic lesions, and infiltrating inflammatory cells. Apoptotic cells were detected by the TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) technique (7) using a kit (Boehringer Mannheim, Quebec, Canada) and the assay was conducted as described in the manufacturer's protocol. The sections were stained with terminal deoxynucleotidyl transferase and counterstained with methyl green. DNase-treated sections were used as a positive control. Negative controls were made by omitting the transferase.
Determination of bacterial growth. For quantitation of bacterial numbers, a limiting-dilution in vitro culture was performed as previously described (52). Briefly, organs including the spleen, liver, lungs, and kidneys were aseptically removed and homogenized. Serial dilutions were plated on Yersinia selective agar plates. CFU were counted after incubation of the plates for 40 h at 24°C.
Measurement of in vitro intracellular killing of bacteria by PEC. Peritoneal exudate cells (PEC) were obtained by intraperitoneal injection with thioglycolate broth and were harvested 3 days later. They were washed and resuspended in balanced salt solution and were incubated for 15 min at 37°C, with rotary stirring, with live Y. enterocolitica in balanced salt solution containing 5% mouse serum. Then the samples were washed three times, 100 µg of gentamicin per ml was added, and the samples were kept on ice for 75 min to remove extracellular bacteria. Subsequently, the samples were incubated for 90 min and the cells were lysed with 1% Triton X-100 for 5 min to release intracellular bacteria. Serial dilutions were made with 0.1 ml plated on an LB agar plate. CFU were counted after incubation of the plate for 40 h at 24°C.
Measurement of nitrite in supernatants from PEC and in sera.
For measurement of nitric oxide production, PEC were prepared as above
and cultured at 106 cells/ml in 96-well tissue culture
plates containing MEM medium (10% fetal calf serum, 2 mM
L-glutamine, 50 U of penicillin per ml, and 50 U of
streptomycin per ml). The cells were stimulated with 100 U of murine
recombinant IFN-
(rIFN-
) (Genzyme, Cambridge, Mass.) per ml and
1,000 pg of rTNF-
(Genzyme) per ml. The supernatants were collected
at 72 h to assess nitric oxide production. Nitrite levels in the
supernatants and in sera were measured by the Griess reaction
(25), using NaNO2 (Sigma, St. Louis, Mo.) as the
standard with a detection limit of 1.66 µm.
Detection of oxidative burst activity in phagocytes in heparinized whole blood. The oxidative burst activity of monocytes and granulocytes was quantified with a test kit (Bursttest; Orpegen Pharma, Heidelberg, Germany). In brief, 100 µl of freshly heparinized whole blood was incubated with the optimized Y. enterocolitica for 10 min at 37°C in a water bath. The samples were then mixed with 20 µl of substrate solution (fluorogenic dihydrorhodamine 123) and incubated for another 10 min at 37°C. The samples were lysed and washed with washing solution. Subsequently, 200 µl of DNA staining solution was added, and the samples were incubated for 10 min at 0°C. The cells were analyzed by flow cytometry using CellQuest software in a FACScan apparatus (Becton Dickinson, Mountain View, Calif.). Dihydrorhodamine 123 is oxidized to rhodamine 123 in the presence of reactive oxidatant intermediates such as H2O2 or O2. Upon excitation at 488 nm, rhodamine 123 emits a fluorescent signal that can be detected at 525 nm. The relevant granulocyte or monocyte/macrophage clusters were gated in the software program in the scatter diagram, and its green fluorescence histogram (FL1) was analyzed. The mean fluorescence was correlated with oxidation quantity per individual phagocyte.
Analysis of cell surface markers of splenocytes by flow cytometry. Splenocytes from uninfected and infected mice were prepared as previously described (53). Briefly, mouse spleens were passed through a nylon mesh and erythrocytes were depleted by hypotonic lysis. The resulting single cells were suspended in 1% bovine serum albumin-PBS and were subsequently analyzed for expression of cell markers by flow cytometry. The cells were incubated with 10 µg of murine immunoglobulin G per ml for 15 min on ice for Fc receptor blocking. Subsequently, the cells were stained with various antibodies for 30 min at 4°C. For single-color analysis, the cells were stained with fluorescein isothiocyanate-conjugated antibodies specific for mouse Mac-1, Fas, or intercellular cell adhesion molecule 1 (ICAM-1) or with phycoerythrin-conjugated anti-B220 (Sigma). For two-color analysis, cells were stained with a combination of phycoerythrin-conjugated anti-CD8 (Sigma) and fluorescein-conjugated anti-CD4 (Sigma) or phycoerythrin-conjugated anti-NK1.1 (PharMingen, San Diego, Calif.) and fluorescein isothiocyanate-conjugated anti-CD3 (PharMingen). Fluorescein isothiocyanate- or phycoerythrin-conjugated rat immunoglobulin G2a served as isotype-matched negative controls (Sigma). At the end of the incubation, the cells were washed and were resuspended in 1% bovine serum albumin-PBS for analysis in a FACScan cytometer with CellQuest TM software (Becton Dickinson). The stained cells were gated using forward and side scatter encompassing lymphocytes or leukocytes.
Cell culture and cytokine assessment.
Splenocytes were
prepared as above and suspended in MEM complete medium, and
106 live cells/ml were incubated with or without 2 µg of
concanavalin A (ConA) (Sigma) per ml. The cultures were maintained in
24-well plates at 37°C in 5% CO2 under 95% humidity.
The supernatants were collected after 24 h for the detection of
TNF and IL-4 or after 72 h for the detection of IFN-
and IL-10.
These time points represent optimal responses as assessed in a pilot
study (data not shown). The cytokine levels in culture supernatants and
in sera were determined by an enzyme-linked immunosorbent assay (ELISA) or bioassay. IFN-
and IL-10 levels were quantified using an ELISA system (PharMingen) as described previously (54). TNF levels were measured by a bioassay using clone 13 of the WEHI 164 cell line as
the target cells (19) (kindly provided by T. Mosmann, University of Alberta) as described previously (52). IL-4
levels were determined by measuring the proliferation of the CT-4S cell line (28) blocked with anti-IL-2 supernatants as described
previously (14). Recombinant murine IL-4, IL-10, IFN-
,
and TNF-
were purchased from Genzyme Corp.
Statistical analysis. Differences between mean values were analyzed by the Mann-Whitney U test and the Student t test. Data are presented as mean and standard deviation obtained from five mice per group.
| |
RESULTS |
|---|
|
|
|---|
Increased resistance to Y. enterocolitica infection at
early stage in TNFRp55
/
mice is accompanied by
decreased apoptosis in the spleen.
To evaluate the impact of
TNFRp55 on the early response to Yersinia infection,
TNFRp55
/
and control C57BL/6 mice were inoculated
intravenously with 350 CFU of Y. enterocolitica and
sacrificed on day 5 after infection. At this time point, no animals had
died of the infection and no clinical evidence of arthritis was
observed in either groups. Unexpectedly, TNFRp55
/
mice
displayed more efficient bacterial clearance from the spleen, liver,
lungs, and kidneys (Fig. 1). CFU counts
were fourfold lower in the spleen and sevenfold lower in the liver in
TNFRp55
/
mice compared with C57BL/6 mice. In parallel
with the less efficient bacterial clearance in spleens, C57BL/6 mice
developed obvious splenomegaly and abscess formation, while
TNFRp55
/
mice had lower spleen weights and fewer
abscesses.
|
/
mice displayed
mild sinusoidal and periportal inflammation, with small foci of
inflammatory infiltrates consisting mainly of mononuclear cells (Fig.
2A). Similar low-grade inflammatory
changes was seen in the spleens (Fig. 2B). Only rare microabscesses
were observed in the sinuses of the spleens and only in a minority of
the animals. In marked contrast to TNFRp55
/
mice,
C57BL/6 mice displayed extensive pyogenic lesions including numerous
macro- or microabscesses in both the liver (Fig. 2C) and the spleen
(Fig. 2D). Large areas of confluent inflammatory infiltrates consisted
of a mixed population of granulocytes and mononuclear cells in necrotic
foci of liver and spleen parenchyma. In addition, marked sinusoidal
congestion, increased extramedullary hematopoiesis, atrophic white
pulp, and collections of phagocytes were detected in the spleens of
C57BL/6 mice.
|
/
and C57BL/6 mice were stained in
the TUNEL assay. No significant difference with respect to apoptosis in
hepatocytes could be detected outside of the abscesses between the
groups (data not shown). However, TUNEL staining revealed a marked
increase in cell death in the spleens of C57BL/6 mice (Fig.
3B) compared with
TNFRp55
/
mice (Fig. 3A). TUNEL-positive cells in
C57BL/6 mice clearly displayed the morphological hallmarks of
programmed cell death characterized by dark, condensed chromatin
juxtaposed against the nuclear membrane, nuclear fragmentation, and
cell shrinkage. Furthermore, there was a notable absence of
inflammatory reaction around dead cells and the TUNEL-positive cells
were seen at sites remote from abscess foci. In contrast to these
changes, the morphology of most of the spleen cells in
TNFRp55
/
mice was intact and only rare scattered cells
were stained in the TUNEL assay.
|
Phagocyte microbicidal activity does not differ at early stage of
the infection between TNFRp55
/
and C57BL/6 mice.
To determine whether the early defense against the bacteria in
TNFRp55
/
was correlated with the microbicidal capacity
of macrophages, macrophages obtained from infected mice on day 5 after
infection were evaluated using PEC elicited by thioglycolate broth. The intracellular killing capacity was assessed by coculture of PEC and
live bacteria for 90 min. TNFRp55
/
and C57BL/6 mice
displayed an equal intracellular killing capacity (71.0% ± 7.8% and
73.3% ± 11.3%, respectively), indicating that TNFRp55
/
mice had no altered macrophage killing of
Yersinia by PEC at this early stage of the infection. Nitric
oxide production was evaluated in sera as well as in culture
supernatants from PEC. As shown in Fig.
4, although decreased nitric oxide
generation by PEC stimulated with rIFN-
and rTNF-
was found in
uninfected TNFRp55
/
mice, no statistical
difference in NO production between the groups was observed on day 5 after infection. Also, there was no difference with respect to serum NO
production between the groups at this time point
(TNFRp55
/
mice, 20.0 ± 8.1 µM; C57BL/6 mice,
21.0 ± 5.0 µM).
|
/
and C57BL/6 mice after stimulation with the
bacteria. The percentages of cells in the granulocyte gate
significantly increased in infected mice versus uninfected mice
(TNFRp55
/
mice, 8.78% ± 2.06% versus 40.34% ± 15.46%; C57BL/6 mice, 9.74% ± 5.26% versus 41.83% ± 11.73%).
Significantly higher fluorescence intensities in monocytes/macrophages
and granulocytes demonstrated that oxidative-burst formation was
increased in both the infected TNFRp55
/
and C57BL/6
mice (Fig. 5). However, no significant
differences between the groups could be detected. Collectively, these
data indicate that TNF signaling via p55 did not alter macrophage
microbicidal activity in terms of NO production or oxidative-burst
activity at early stages of Y. enterocolitica infection.
|
The early resistance in TNFRp55
/
mice is associated
with increased IFN-
and decreased IL-10 production by
splenocytes.
Cytokine levels were measured in sera and in culture
supernatants of splenocytes from uninfected mice or day 5 after
infection. Comparable levels of TNF were detected in the sera and the
culture supernatants of splenocytes stimulated with ConA in both groups (data not shown). IFN-
production by splenocytes was lower in response to ConA in uninfected TNFRp55
/
mice (258 ± 84 U/ml) than in the controls (490 ± 26 U/ml) (Fig. 6A). Strikingly, almost
threefold-increased levels of IFN-
in response to ConA were detected
in TNFRp55
/
mice (743 ± 191 U/ml) (Fig. 6B)
following Yersinia infection, while C57BL/6 mice (344 ± 123 U/ml) displayed decreased IFN-
production upon stimulation
with ConA compared with that before infection. Elevated IFN-
levels
in TNFRp55
/
mice were also noticed in the supernatants
obtained from unstimulated cultures of splenocytes (Fig. 6B) and in the
sera (40 ± 22 versus 21 ± 7) compared with C57BL/6 mice,
although no statistical difference was observed. In contrast to IFN-
production, IL-10 levels in culture supernatants of splenocytes
stimulated with ConA were higher in uninfected TNFRp55
/
mice than in the controls (Fig. 7A).
However, significantly decreased IL-10 levels in
TNFRp55
/
mice were observed in unstimulated splenocytes
compared with the controls on day 5 after infection (Fig. 7B). Low
levels of IL-4 were detected, but no difference could be detected in
infected mice between the groups (data not shown).
|
|
The frequencies of spleen CD4+ T cells in
TNFRp55
/
mice are less decreased at early stages during
the infection.
To further evaluate cell death in the splenocyte
population, the viability of splenic mononuclear cells was assessed by
trypan blue staining and the proportion of lymphocyte subsets was
assessed by flow cytometry analysis. In C57BL/6 mice, 25% of the
splenocytes died compared with only 10% of the splenocytes in
TNFRp55
/
mice. As demonstrated in Table
1, phenotypic expression of
CD4+, CD8+, NK, and B220+ cells was
similar in lymphocytes from the uninfected TNFRp55
/
and
C57BL/6 mice. Following infection with Y. enterocolitica, no
statistical differences with respect to CD8+, NK, and
B220+ cells were found between the groups. However,
markedly decreased frequencies of CD4+ T cells were
detected in C57BL/6 mice, while TNFRp55
/
mice displayed
only a slightly decreased percentage of CD4+ T cells. The
total numbers of splenic CD4+ T cells in infected
TNFRp55
/
mice reflected a 4.5-fold increase (13.1 × 106 ± 2.1 × 106) compared with
baseline values (2.9 × 106 ± 1.0 × 106). The total number of CD4+ T cells
(10.2 × 106 ± 1.7 × 106) in
C57BL/6 mice was smaller than in TNFRp55
/
mice on day 5 after infection and only 2.5-fold increased compared with that before
infection (3.9 × 106 ± 1.7 × 106). The percentage of Mac-1+ cells was lower
in both uninfected and infected TNFRp55
/
mice than in
controls (Table 1). In addition, no statistical differences were
observed with respect to the expression of Fas, NK1.1 T cells, and
CD62L between the groups (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
The role of TNFRp55 in the early host response to
Yersinia infection was investigated by the use of
TNFRp55
/
mice. TNFRp55
/
mice proved to
be relatively more resistant to Yersinia infection at the
early stages, as manifested by more efficient bacterial clearance and
reduced tissue damage compared with the controls. It appears that TNF
signaling via TNFRp55 was deleterious rather than beneficial in the
early host response to Yersinia infection. In studying the
cellular sources accounting for the increased resistance, we found no
difference with respect to macrophage microbicidal activity between the
groups, indicating that the absence of TNFRp55 signaling did not
influence the macrophage function in the early response to
Yersinia and that macrophage microbicidal activity is not a
determining factor in the early defense against Yersinia.
Likewise, the comparable increase in numbers of circulating
granulocytes in the groups indicated that this was not a differential
variable. In addition, the frequencies of NK cells, a cell type that
has been proposed to be critical in early Yersinia infection
(8), did not show any difference between the groups. In
contrast, the significant and dramatic decrease in the percentages of
splenic CD4+ T cells in C57BL/6 mice was not observed in
TNFRp55
/
mice. C57BL/6 mice demonstrated extensive cell
death in the spleen, to a far greater degree than was observed in
TNFRp55
/
mice. Concomitant with these cellular events,
cytokine analyses demonstrated increased IFN-
and decreased IL-10
production in TNFRp55
/
mice compared with C57BL/6 mice.
Thus, in the acute phase of infection, TNFRp55-mediated signaling
events precipitate a relative decline in splenic CD4+ T
cells, with important consequences for the host response to the pathogen.
Previous studies have noted an association between the virulence of
Yersinia pestis and suppression of host TNF production (35, 36). More recently, Schmidt et al. (46) have
observed that the 39-kDa V antigen of Yersinia spp.
suppresses TNF production through a pathway involving activated
CD4+ and CD8+ T cells. These studies have
largely utilized in vitro systems and have not addressed this issue
following in vivo challenge of an animal with Y. enterocolitica. Whatever countermeasures Yersinia may
possess (such as Vag) against host defensive cytokines, it is evident
in our in vivo system that they are inadequate in suppressing a host
TNF response in the acute phase of the infection, of which the sequela
is splenocyte apoptosis. TNF can induce cytotoxicity either by necrosis
or by apoptosis (22). It is known that TNFRp55-mediated apoptosis is mediated through a death domain, homologous to the Fas
death domain (30, 47, 49). Yersinia-triggered
apoptosis has been demonstrated in examining the interaction of
Y. enterocolitica with macrophages or epithelial cells
(32, 43). Interestingly, epithelial HeLa cells undergo
apoptosis upon Yersinia infection only when TNF-
is
present simultaneously, indicating that Yersinia-induced apoptosis is in part mediated through the TNF signaling pathway (43). Recently, Monack et al. have reported that Y. pseudotuberculosis infection in BALB/c mice induces apoptosis of
Mac-1+ cells in the mesenteric lymph nodes and spleens
(33), but the effect on the T-cell populations was not
examined. In the present study, the cellular basis of the extensive
apoptosis remains to be defined. It is of interest that a higher degree
of apoptosis in spleens in C57BL/6 mice than in
TNFRp55
/
mice was associated with a much greater
decline in the total numbers and percentages of CD4+ T cells.
It has been recognized that death of activated T cells can be mediated
by interaction between TNF and TNF receptors (15, 44, 50).
Activation-induced CD4+-T-cell death by apoptosis is a
prominent feature of a number of infectious diseases, such as human
immunodeficiency virus infection (29), experimental Chagas'
disease (31), and Schistosoma mansoni infection
(21). In these studies, selective triggering of
CD4+-T-cell death resulted in a global immunosuppression in
infected hosts. In the present study, the proportion of splenic
CD4+ T cells markedly decreased in C57BL/6 mice, which
correlated with dramatically increased numbers of apoptotic cells, as
demonstrated by the TUNEL assay. This suggests that Yersinia
infection might trigger CD4+ T cells to undergo programmed
death from the TNFRp55 signaling. In contrast to C57BL/6 mice,
TNFRp55
/
mice displayed less apoptosis in
their spleens, associated with more efficient bacterial clearance and
reduced tissue damage, indicating that the induction of apoptosis may
figure critically in early resistance to Yersinia. In
addition to apoptosis, large necrotic lesions and scattered necrotic
cells in the spleens of C57BL/6 mice might also be TNFRp55 dependent,
since TNF has been suggested to be needed for lysis of microbe-infected
cells (39). It should noted that not only the numbers but
also the activities might also be altered in CD4+ T cells
in the absence of TNFRp55, since TNF can suppress the T-cell response
via modulation of T-cell receptor signaling (16). In
accordance with this finding, several studies have shown that chronic
TNF-
administration reduces both the number and function of splenic
T cells and thus induces a preferential inhibition of cell-mediated
immunity (24, 40).
CD4+ T cells are believed to mediate acquired immunity in
bacterial infection, generally by means of cytokine production. The extent to which CD4+ T cells contribute to the early stage
of Yersinia infection has not been defined. CD4+
T cells play a critical role in resistance to Yersinia by
producing Th1 cytokines such as IFN-
. It has been shown that NK
cells are the major source of IFN-
production on day 3 (2,
4). Thereafter, activated CD4+ T cells produce most
of the IFN-
following infection with Yersinia (2,
4). IFN-
derived from NK cells can be compensated by CD4+-T-cell production, while IFN-
derived from
CD4+ T cells is essential and irreplaceable in terms of
protection against Yersinia (8). In our
experiments, the markedly increased total number of CD4+ T
cells and the pronounced production of IFN-
on day 5 after infection
are probably related events and might be one of the mechanisms for the
early defense against Yersinia in the absence of
TNFRp55. Another postulated role for CD4+ T cells in
the early stage of Yersinia infection is that they could
provide signals for the early activation of B cells, macrophages, and
dendritic cells through CD28-B7 and CD40-CD40L interactions. These
activated cells might then contribute to the course of the infection by
enhanced presentation of antigens, cytokine release, and antibody
production. This notion is supported by a previous study demonstrating
that administration of a sublethal dose of Y. enterocolitica
causes the death of T-cell-deficient nude mice from severe infection
within the first few days (4). Moreover, the studies with
experimental Leishmania major infection have also suggested
that 
-positive T cells, especially CD4+ T cells, may
be crucial in early protection against microbes, since depletion of NK
or 
-positive T cells did not reverse disease outcome in resistant
mice (42, 45).
IFN-
, in synergy with TNF-
, is known to be a key mediator in
resistance to Yersinia infection. Early and enhanced IFN-
mRNA is associated with a state of heightened resistance to
Yersinia infection (9). Administration of
recombinant IFN-
rendered susceptible BALB/c mice resistant to
infection (8). Moreover, anti-IFN-
treatment abrogated
the resistance to the infection (3). IFN-
is believed to
be one of the essential stimulators of macrophage microbicidal activity
and therefore is crucial for resistance to Yersinia
infection (3, 9). In the present study, decreased IFN-
production by splenocytes in response to ConA was found in uninfected
TNFRp55
/
mice, indicating that TNF is required for
optimal IFN-
production, as demonstrated previously (27).
The elevated IFN-
production following infection resulted in part
from the increased absolute number of Th1-type CD4+ T cells
in these mice. TNFRp55
/
mice might also develop rapid
regulatory feedback mechanisms upon administration of the bacteria. For
instance, decreased IL-10 levels might contribute to the increased
level of IFN-
, since IL-10 downregulates CD4+ Th1
cytokine production (34). High levels of IFN-
may be
sufficient to effectively activate macrophages in the early events
following infection in the absence of TNFRp55. In this regard, we do
not exclude the possibility that TNFRp75 compensates for the absence of
TNFRp55 in activating macrophages at early stages of the infection.
A hypothesis proposed herein might explain the disparate roles of
TNFRp55 signaling during Y. enterocolitica infection. At early stages of the infection, Yersinia-triggered,
TNFRp55-mediated apoptosis of CD4+ T cells occurs in normal
mice. TNFRp55
/
mice are spared this relative depletion
of T cells and are able to mount a protective IFN-
response acutely.
Increased IFN-
and decreased IL-10 might be the key effectors for
this early control of Yersinia in TNFRp55
/
mice. As the infection proceeds, macrophages activated by TNF signaling
via TNFRp55 may become critical for clearance of the bacteria. It may
be that the enhanced temporary presence of bacteria and death of
splenocytes in C57BL/6 mice at early stages is a necessary component of
an effective adaptive immune response to Yersinia, resulting
in later resistance to Yersinia. Such a hypothesis suggests
a dynamic balance between beneficial and deleterious roles for TNFRp55
in bacterial infection and defines TNF as a key player in orchestrating
host reactivity during the different stages of the bacterial infection.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Arthritis Society and the Medical Research Council of Canada. Y.-X. Zhao is a recipient of research fellowship award from the Medical Research Council of Canada.
We thank J. Wither, Department of Immunology, University of Toronto,
for kindly providing IFN-
and IL-10 ELISA reagents.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The Toronto Hospital Arthritis Center, The Toronto Hospital, 399 Bathurst St., Toronto, Ontario, M5T 2S8, Canada. Phone: (416) 603-5869. Fax: (416) 603-4348. E-mail: rinman{at}torhosp.toronto.on.ca.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Autenrieth, I. B.,
M. Beer,
E. Bohn,
S. H. E. Kaufmann, and J. Heeseman.
1994.
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon.
Infect. Immun.
62:2590-2599 |
| 2. | Autenrieth, I. B., P. Hantschmann, B. Heymer, and J. Heeseman. 1993. Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes. Immunobiology 187:1-16[Medline]. |
| 3. | Autenrieth, I. B., and J. Heeseman. 1992. In vivo neutralization of tumor necrosis factor alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica in mice. Med. Microbiol. Immunol. 181:333-338[Medline]. |
| 4. |
Autenrieth, I. B.,
V. Vogel,
S. Preger,
B. Heymer, and J. Heeseman.
1993.
Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response.
Infect. Immun.
61:2585-2595 |
| 5. |
Autenrieth, I. B.,
A. Tingle,
A. Reske-Kunz, and J. Heesemann.
1992.
T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cells clones specific for Y. enterocolitica.
Infect. Immun.
60:1140-1149 |
| 6. | Bemelmans, M. H. A., L. J. H. van Tits, and W. A. Buurman. 1996. Tumor necrosis factor. Crit. Rev. Immunol. 16:1-11[Medline]. |
| 7. | Ben-Sasson, S., Y. Sherman, and Y. Gavrieli. 1995. Identification of dying cells: in situ staining. Methods Cell Biol. 46:29-39[Medline]. |
| 8. |
Bohn, E., and I. B. Autenrieth.
1996.
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN- production in NK cells and CD4+ T cells.
J. Immunol.
156:1458-1468[Abstract].
|
| 9. |
Bohn, E.,
J. Heesemann,
S. Ehlers, and I. B. Autenrieth.
1994.
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica.
Infect. Immun.
62:3027-3032 |
| 10. |
Bohn, E.,
E. Schmitt,
C. Bielfeldt,
A. Noll,
R. Schulte, and I. Autenrieth.
1998.
Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.
Infect. Immun.
66:2213-2220 |
| 11. |
Bohn, E.,
A. Sing,
R. Zumbihl,
C. Bieleldt,
H. Okamura,
M. Kurimoto,
J. Heesemann, and I. B. Autenrieth.
1998.
IL-18 (IFN- -inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice.
J. Immunol.
160:299-307 |
| 12. | Bouza, E., A. Dominguez, M. Meseguer, L. Buzon, M. Boixeda, M. J. Revillo, L. de Rafael, and J. Martinez Beltran. 1980. Yersinia enterocolitica septicemia. Am. J. Clin. Pathol. 74:404-409[Medline]. |
| 13. | Buedack, S. S., A. E. Knieschies, M. Rollinghoff, and H. U. Beuscher. 1997. Tumor necrosis factor-alpha expression induced by anti-YopB antibodies coincides with protection against Yersinia enterocolitica infection in mice. Med. Microbiol. Immunol. 185:223-229[CrossRef][Medline]. |
| 14. |
Chu, N. R.,
M. A. DeBenedette,
B. J. Niclas Stiernholm,
B. H. Barber, and T. H. Watts.
1997.
Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28 T cells.
J. Immunol.
158:3081-3089[Abstract].
|
| 15. |
Clement, M.-V., and I. Stamenkovic.
1994.
Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.
J. Exp. Med.
180:557-567 |
| 16. |
Cope, A.,
R. Liblau,
X. Yang,
M. Congia,
C. Laudanna,
R. Schreiber,
L. Probert,
G. Kollias, and H. McDevitt.
1997.
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.
J. Exp. Med.
185:1573 |
| 17. | Cover, T. L., and R. C. Aber. 1989. Yersinia enterocolitica. N. Engl. J. Med. 321:16-24[Medline]. |
| 18. |
Endres, R.,
A. Luz,
H. Schulze,
H. Neubauer,
A. Futterer,
S. M. Holland,
H. Wagner, and K. Pfeffer.
1997.
Listeriosis in p47phox / and TRp55 / mice: protection despite absence of ROI and susceptibility despite presence of RNI.
Immunity
7:419-432[CrossRef][Medline].
|
| 19. | Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105[CrossRef][Medline]. |
| 20. |
Everest, P.,
M. Roberts, and G. Gougan.
1998.
Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor.
Infect. Immun.
66:3355-3364 |
| 21. | Fallon, P., P. Smith, and D. Dunne. 1998. Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cell in acute Schistomoma mansoni infection. Eur. J. Immunol. 28:1408-1416[CrossRef][Medline]. |
| 22. | Fiers, W., R. Beyaert, E. Boone, S. Cornelis, W. Declercq, E. Decoster, G. Denecker, B. Depuydt, D. De Valck, G. De Wilde, V. Goossens, J. Grooten, G. Haegeman, K. Heyninck, L. Penning, S. Plaisance, K. Vancompernolle, W. Van Criekinge, P. Vandenabeele, W. Vanden Berghe, M. Van de Craen, V. Vandevoorde, and D. Vercammen. 1996. TNF-induced intracellular signalling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J. Inflamm. 47:67-75. |
| 23. |
Flynn, J. L.,
M. M. Goldstein,
J. Chan,
K. J. Triebold,
K. Pfeffer,
C. J. Lowenstein,
R. Schreiber,
T. W. Mak, and B. R. Bloom.
1995.
Tumor necrosis factor- is required in the protective immune response against Mycobacterium tuberculosis in mice.
Immunity
2:561-572[CrossRef][Medline].
|
| 24. |
Gordon, C., and D. Wofsy.
1990.
Effects of recombinant murine tumor necrosis factor- on immune function.
J. Immunol.
144:1753-1758[Abstract].
|
| 25. | Green, L., D. Wagner, J. Glogowski, P. Skipper, J. Wishnok, and S. Tannenbaum. 1982. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126:131-138[CrossRef][Medline]. |
| 26. |
Gripenberg-Lerche, C., and P. Toivanen.
1993.
Yersinia associated arthritis in SHR rats: effect of the microbial status of the host.
Ann. Rheum. Dis.
52:223-228 |
| 27. |
Hsieh, C.,
S. Macatonia,
A. Ogarra, and K. Murphy.
1993.
Pathogen-induced Th1 phenotype development in CD4+ alpha-beta-TCR transgenic T-cells is macrophage dependent.
Int. Immunol.
5:371 |
| 28. | Hu-Li, J., J. Ohara, C. Watyson, W. Tsang, and W. E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800-807[Abstract]. |
| 29. |
Ledru, E.,
H. Lecoeur,
S. Garcia,
T. Debord, and M. Gougeon.
1998.
Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.
J. Immunol.
160:3194-3206 |
| 30. | Leist, M., F. Ganter, S. Jilg, and A. Wendel. 1995. Activation of the p55-kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154:1307[Abstract]. |
| 31. | Lopes, M., V. da Veiga, A. Santos, M. Fonseca, and G. DosReis. 1995. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154:744-752[Abstract]. |
| 32. |
Mills, S.,
A. Boland,
M.-P. Sory,
P. van der Smissen,
C. Kerbourch,
B. Finlay, and G. Cornelis.
1997.
Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein.
Proc. Natl. Acad. Sci. USA
94:12638-12643 |
| 33. |
Monack, D.,
J. Mecsas,
D. Bouley, and S. Falkow.
1998.
Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice.
J. Exp. Med.
188:2127-2137 |
| 34. | Mosmann, T., and K. Moore. 1991. The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol. Today 12:A49-A53[CrossRef][Medline]. |
| 35. |
Nakajima, R., and R. R. Brubaker.
1993.
Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
Infect. Immun.
61:23-31 |
| 36. | Nakajima, R., V. L. Motin, and R. R. Brubaker. 1995. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63:3021-3029[Abstract]. |
| 37. |
Nashleanas, M.,
S. Kanaly, and P. Scott.
1998.
Control of Leishmania major infection in mice lacking TNF receptors.
J. Immunol.
160:5506-5513 |
| 38. | Pfeffer, K., Y. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Krönke, and T. M. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467[CrossRef][Medline]. |
| 39. | Portnoy, D. 1992. Innate immunity to a facultative intracellular bacterial pathogen. Curr. Opin. Immunol. 4:20-24[CrossRef][Medline]. |
| 40. |
Rabinovitch, A.,
W. Suarez-Pinzon,
O. Sorensen,
R. Rajotte, and R. Power.
1997.
TNF- down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
J. Immunol.
159:6298-6303[Abstract].
|
| 41. | Roggenkamp, A., H. R. Neuberger, A. Flugel, T. Schmoll, and J. Heesemann. 1995. Substitution of two histidine residues in Yad A protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol. Microbiol. 16:1207-1219[Medline]. |
| 42. | Rosat, J., H. MacDonald, and J. Louis. 1993. A role for gamma delta+ T cells during experimental infection of mice with Leishmania major. J. Immunol. 150:550-555[Abstract]. |
| 43. |
Ruckdeschel, K.,
S. Harb,
A. Roggenkamp,
M. Hornef,
R. Zumbihl,
S. K hler,
J. Heesemann, and B. Rouot.
1998.
Yersinia enterocolitica impaires activation of transcription factor NF-kB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor production.
J. Exp. Med.
187:1069-1079 |
| 44. | Sarin, A., M. Conan-Cibotti, and P. Henkart. 1995. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155:3716-3718[Abstract]. |
| 45. |
Scharton, T., and P. Scott.
1993.
Natural killer cells are a source of interferon that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
J. Exp. Med.
178:567-577 |
| 46. | Schmidt, A., M. Röllinghoff, and H. U. Beuscher. 1999. Suppression of TNF by V antigen of Yersinia spp. involves activated T cells. Eur. J. Immunol. 29:1149-1157[CrossRef][Medline]. |
| 47. |
Tartaglia, L.,
M. Rothe,
Y. Hu, and D. Goeddel.
1993.
Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF- receptor.
Cell
73:213-216[CrossRef][Medline].
|
| 48. | Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827-835[Abstract]. |
| 49. | Wong, G., and D. Goeddel. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751[Abstract]. |
| 50. | Wong, G., and D. Goeddle. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751-1755. |
| 51. |
Yap, G.,
T. Scharton-Kersten,
H. Charest, and A. Sher.
1998.
Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo.
J. Immunol.
160:1340-1345 |
| 52. | Zhao, Y.-X., A. Abdelnour, R. Holmdahl, and A. Tarkowski. 1995. Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J. Immunol. 155:2067-2076[Abstract]. |
| 53. |
Zhao, Y.-X.,
A. Abdelnour,
A. Ljungdahl,
T. Olsson, and A. Tarkowski.
1995.
Patterns of interferon- mRNA expression in toxic shock syndrome toxin-1 expanded V 11+ T lymphocytes.
Cell. Immunol.
161:28-33[CrossRef][Medline].
|
| 54. | Zhao, Y.-X., H. Zhang, B. Chiu, U. Payne, and R. D. Inman. 1999. Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection. Arthritis Rheum. 42:1662-1672[CrossRef][Medline]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||